A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2009
12/09/2009	CN101596158A Compound slow release preparation of acetyl aminophenol, pseudoephedrine and dextromethorphan
12/09/2009	CN101596157A Compound slow release preparation of pseudoephedrine, chlorphenamine and dextromethorphan
12/09/2009	CN101596156A Compound sustained-release preparation for paracetamol and pseudoephedrine
12/09/2009	CN101595874A Validamycin amphiphilic polymer network and synthesis method thereof
12/09/2009	CN100568056C Flexible conea contact lenses with antibacterial performance, its production and application
12/09/2009	CN100567488C Enhancement of virus-mediated DNA transfer
12/09/2009	CN100567345C Method for preparing polymer nano micelle by water solution polymerization self-emulsification method
12/09/2009	CN100567253C Novel succinate salt of O-demethyl-venlafaxine
12/09/2009	CN100566758C Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
12/09/2009	CN100566757C Biological degradable polymer-solid liposome sustained-release storing system and preparation method thereof
12/09/2009	CN100566756C Pharmaceutical compositions comprising polyethylene glycol having a molecular weight of less than 600 daltons
12/09/2009	CN100566755C Polymer particles containing active agents
12/09/2009	CN100566754C Gelling agent for controlling and releasing 5-HT3 acceptor antagon and method of preparing the same
12/09/2009	CN100566724C Middle gut positioning sausage dissolvable pharmaceutical formulations for relieving diarrhea and processes for their preparation
12/09/2009	CN100566708C Method of producing hepatic targeting drug microcapsule
12/09/2009	CN100566707C Hericiaceae contained Jianweiling capsules for stomach disease
12/09/2009	CN100566704C Sodium fusidate freezing-dried powder injection
12/08/2009	US7629388 Crosslinked polyester; enhanced cell adhesion
12/08/2009	US7629314 Methods for making proteins containing free cysteine residues
12/08/2009	US7629147 PEGylated soluble GP130-dimers useful as a medicament
12/08/2009	US7629005 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
12/08/2009	US7629003 Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
12/08/2009	US7628997 Via bioactive glass particles
12/08/2009	US7628989 Methods of inducing an immune response
12/08/2009	US7628987 Vectors derived from antibodies for transferring substances into cells
12/08/2009	US7628986 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
12/08/2009	US7628978 Stabilized preparations for use in metered dose inhalers
12/08/2009	US7628977 Particles for inhalation having sustained release properties
12/08/2009	CA2481994C Personal care compositions comprising a zinc containing material in an aqueous surfactant composition
12/08/2009	CA2452827C Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug
12/08/2009	CA2400371C Methods to prepare micelles comprising amphiphilic lipopolysaccharide compounds
12/08/2009	CA2386720C Alcohol based topical anesthetic formulation and method
12/08/2009	CA2378557C Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration
12/08/2009	CA2347907C Formulations for topical application of substances having an antiandrogenic action
12/08/2009	CA2347424C Use of dextran covalently bound to charged groups for selective targeting of tumor by local, intratumoral or intracavitary administration
12/08/2009	CA2338750C Coating and binding agent for oral or dermal pharmaceutical forms
12/08/2009	CA2333076C Topical application of muscarinic analgesic drugs such as neostigmine
12/08/2009	CA2329046C Composition comprising l-ascorbic acid and pectin
12/08/2009	CA2322845C Emulsion preconcentrates containing cyclosporin or a macrolide
12/08/2009	CA2302275C Solid solution beadlet
12/08/2009	CA2222646C Compositions and methods for stabilizing polymers
12/05/2009	CA2632926A1 Solubilized benzoyl peroxide topical drug formulation for treatment of acne
12/03/2009	WO2009146153A2 Manufacture, transport and delivery of material containing highly polarized nuclei
12/03/2009	WO2009146147A2 Target-responsive hydrogels
12/03/2009	WO2009146097A1 Raloxifene pharmaceutical formulations
12/03/2009	WO2009145982A1 Compositions and methods for skin care
12/03/2009	WO2009145716A1 New pharmaceutical formulation useful in gerd therapy
12/03/2009	WO2009145356A1 Method and composition for treating ocular hypertension and glaucoma
12/03/2009	WO2009145243A1 Lipid membrane applicable to photodynamic therapy and application thereof
12/03/2009	WO2009145177A1 Donepezil-containing patch preparation and packaging thereof
12/03/2009	WO2009144974A1 Method of monitoring mixed state of lubricant ingredient in medicinal preparation
12/03/2009	WO2009144927A1 Drug-containing composition
12/03/2009	WO2009144775A1 Anti-tumor agent
12/03/2009	WO2009144659A1 Azide modified proteins
12/03/2009	WO2009144577A2 Anionic polyamide functionalized by a tryptophan unit
12/03/2009	WO2009144569A2 Hydrogel capable of containing and conveying cells
12/03/2009	WO2009144230A1 Protamine/rna nanoparticles for immunostimulation
12/03/2009	WO2009143558A1 Injectable formulations
12/03/2009	WO2009129094A3 Combinations of antiviral agents and other compounds
12/03/2009	WO2009125975A3 Combination of mitiglinide and metformin and process for preparing same
12/03/2009	WO2009121945A3 Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
12/03/2009	WO2009108935A3 Method and apparatus for impregnating porous biomaterials with bioactive agents
12/03/2009	WO2009107983A3 Stabilized single-liquid pharmaceutical composition containing docetaxel
12/03/2009	WO2009105265A3 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
12/03/2009	WO2009102814A3 Mucosally non-irritative liquid amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis
12/03/2009	WO2009100275A3 Compositions and devices
12/03/2009	WO2009098716A3 Stabilized aqueous formulation containing paracetamol
12/03/2009	WO2009083520A3 Liquid oral florfenicol compositions which can be diluted in drinking water
12/03/2009	WO2009055027A3 Molecular transporter compositions comprising dendrimeric oligoguanidine with a tri-functional core that facilitate delivery into cells in vivo
12/03/2009	WO2009038605A3 Flexible, polyvalent antiviral dendridic conjugates for the treatment of hiv/aids and enveloped viral infection
12/03/2009	WO2009032605A3 Bi-functional polymer-attached inhibitors of influenza virus
12/03/2009	WO2008054544A3 Method for delivery across the blood brain barrier
12/03/2009	WO2006124737A3 Molecular constructs suitable for targeted conjugates
12/03/2009	US20090299127 Magnet-Field Controlled Active Substance Transfer for Aerosol Therapy
12/03/2009	US20090299050 Multi-Arm Block Copolymers as Drug Delivery Vehicles
12/03/2009	US20090298956 Self-preserved emulsions
12/03/2009	US20090298955 Altered virus capsid protein and use thereof
12/03/2009	US20090298954 Affinity Carrier and Method for Producing Thereof
12/03/2009	US20090298953 Drug delivery system and method of making the same
12/03/2009	US20090298952 Platable soluble dyes
12/03/2009	US20090298929 Novel natural cyclodextrin complexes
12/03/2009	US20090298919 Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/03/2009	US20090298915 Topical drug delivery
12/03/2009	US20090298742 Process for manufacturing lactose
12/03/2009	US20090298154 Conjugated biological molecules and their preparation
12/03/2009	US20090297619 Nanoparticulate anticonvulsant and immunosuppressive compositions
12/03/2009	US20090297615 Nanoparticles, methods of making same and cell labeling using same
12/03/2009	US20090297598 Therapeutic combination
12/03/2009	US20090297585 pH Modulated Films for Delivery of Actives
12/03/2009	US20090297567 Method For Ultrasound Triggered Drug Delivery Using Hollow Microbubbles With Controlled Fragility
12/03/2009	US20090297551 Adjuvant
12/03/2009	US20090297538 Neurotoxic oligomers
12/03/2009	US20090297483 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
12/03/2009	US20090297450 Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/03/2009	US20090294360 Dialysis preparation
12/03/2009	DE20122900U1 Ubichinon Konzentrat Ubiquinone concentrate
12/03/2009	CA2724502A1 Adhesive preparation containing donepezil, and package of the same
12/03/2009	CA2724194A1 Method and composition for treating ocular hypertension and glaucoma
12/03/2009	CA2720333A1 Manufacture, transport and delivery of material containing highly polarized nuclei
12/03/2009	CA2719658A1 Compositions and methods for skin care

1 ... 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 ... 1712